BIND Therapeutics beats by $0.01, misses on revenues

|About: BIND Therapeutics, Inc. (BIND)|By:, SA News Editor

BIND Therapeutics (BIND): Q1 EPS of -$0.51 beats by $0.01.

Revenue of $1.56M (+5.2% Y/Y) misses by $0.9M.